Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06770088 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vunakizumab in Adults with Spondyloarthritis

Name: Vunakizumab in Adults with Spondyloarthritis — clinical trial record (NCT06770088)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: V SPA

StatusNot Yet Recruiting

PhasePhase 4

SponsorSun Yat-sen University

Started2025-01-10

View on ClinicalTrials.gov ↗

Record status

This record was last updated January 13, 2025 (before its estimated January 10, 2026 completion). Its status may not reflect the trial's current state.

Sun Yat-sen University

609 trials monitored

See 13 trials at risk

This prospective, single-arm, multicenter study is aimed to explore the efficacy and safety of Vunakizumab in adults with spondyloarthritis. The primary endpoint is the proportion of adults with spondyloarthritis achieving ankylosing spondylitis assessment score (ASAS) 40 at week 16 in the treatment of Vunakizumab.

Trial Details

NCT Number	NCT06770088
Lead Sponsor	Sun Yat-sen University
Conditions	Spondyloarthritis (SpA)
Enrollment	880 participants
Start Date	2025-01-10
Primary Completion	2026-01-10 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-01-13